Zobrazeno 1 - 10
of 48
pro vyhledávání: '"wc_770"'
Autor:
Julie Balen, Umberto D'Alessandro, Nuredin Mohammed, Yoriko Masunaga, Joseph Okebe, Amadou Bah, Edgard Dabira, Ndey-Fatou Drammeh, Fatou Jaiteh, Joan Muela Ribera, John S. Bradley, Shunmay Yeung, Koen Peeters Grietens, Jane Achan
Publikováno v:
Malaria Journal
Malaria Journal, Vol 20, Iss 1, Pp 1-12 (2021)
Malaria Journal, Vol 20, Iss 1, Pp 1-12 (2021)
Background Selectively targeting and treating malaria-infected individuals may further decrease parasite carriage in low-burden settings. Using a trans-disciplinary approach, a reactive treatment strategy to reduce Plasmodium falciparum prevalence in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a92c156459652c01cf0057d0c6f2e8
Autor:
Andrew Blanshard, Paul Hine
Publikováno v:
The Cochrane Database of Systematic Reviews
Background The World Health Organization (WHO) in 2015 stated atovaquone‐proguanil can be used in travellers, and is an option in malaria‐endemic areas in combination with artesunate, as an alternative treatment where first‐line artemisinin‐b
Publikováno v:
The Lancet Infectious Diseases
The Lancet Infectious Diseases, 2020, 20 (1), pp.e20-e25. ⟨10.1016/s1473-3099(19)30426-8⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, 20 (1), pp.e20-e25. ⟨10.1016/s1473-3099(19)30426-8⟩
The Lancet Infectious Diseases, 2020, 20 (1), pp.e20-e25. ⟨10.1016/s1473-3099(19)30426-8⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2020, 20 (1), pp.e20-e25. ⟨10.1016/s1473-3099(19)30426-8⟩
International audience; Malaria drug trials conducted in endemic areas face a major challenge in their analysis because it is difficult to establish whether parasitaemia in blood samples collected after treatment indicate drug failure or a new infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8920d727b27d134a9aa3527fc584b2dd
https://cnrs.hal.science/hal-03059787/document
https://cnrs.hal.science/hal-03059787/document
Publikováno v:
J Antimicrob Chemother
Objectives Rapid rate-of-kill (RoK) is a key parameter in the target candidate profile 1 (TCP1) for the next-generation antimalarial drugs for uncomplicated malaria, termed Single Encounter Radical Cure and Prophylaxis (SERCaP). TCP1 aims to rapidly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6962b431c4edf6c65c63b36b43000a14
https://europepmc.org/articles/PMC8204706/
https://europepmc.org/articles/PMC8204706/
Publikováno v:
The Cochrane Database of Systematic Reviews
Cochrane Database Syst Rev
The Cochrane database of systematic reviews
Cochrane Database of Systematic Reviews
The Cochrane Library
Cochrane Database Syst Rev
The Cochrane database of systematic reviews
Cochrane Database of Systematic Reviews
The Cochrane Library
Background Malaria caused by Plasmodium vivax requires treatment of the blood‐stage infection and treatment of the hypnozoites that develop in the liver. This is a challenge to effective case management of P vivax malaria, as well as being a more g
Publikováno v:
The Cochrane Database of Systematic Reviews
The Cochrane Library
The Cochrane Library
Background Malaria causes ill health and death in Africa. Treating illness promptly with artemisinin-based combination therapy (ACT) is likely to cure people and avoid the disease progressing to more severe forms and death. In many countries, ACT use
Autor:
Pulford, Justin, Jeffrey, Caroline
Introduction: The presumptive treatment of febrile illness with antimalarial medication is becoming less common in low- and middle-income countries as access to reliable diagnostic tests improves. We explore whether the shift towards test-based antim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::15a9f78424fc631758fabd9eb03bbfc2
Autor:
Chen, Tao
Background\ud Ivermectin is being considered for mass-drug-administration for malaria due to its ability to kill mosquitoes feeding on recently treated individuals. However, standard, single-doses of 150-200 mcg/kg used for onchocerciasis and lymphat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6194a2e0fdfd23a31987ab16a1735393
Autor:
Frank Baiden, David Schellenberg, Anthony K. Mbonye, S. Patrick Kachur, Ismail Mayan, Katia Bruxvoort, Catherine Goodman, Heidi Hopkins, Toby Leslie, Seth Owusu-Agyei, Shunmay Yeung, Baptiste Leurent, Kristian S. Hansen, Mark Rowland, Siân E. Clarke, Clare I R Chandler, Delér Shakely, Bonnie Cundill, Anders Björkman, Lasse S Vestergaard, Mwinyi I. Msellem, Sham Lal, Debora D DiLiberto, Helen E. D. Burchett, Lindsay Mangham-Jefferies, Pascal Magnussen, Obinna Onwujekwe, Jayne Webster, Andreas Mårtensson, Kristina Elfving, Virginia Wiseman, Christopher J. M. Whitty, Evelyn K. Ansah, Sarah G. Staedke, David G. Lalloo
Publikováno v:
Bruxvoort, K J, Leurent, B, Chandler, C I R, Ansah, E K, Baiden, F, Björkman, A, Burchett, H E D, Clarke, S E, Cundill, B, DiLiberto, D D, Elfving, K, Goodman, C, Hansen, K S, Kachur, S P, Lal, S, Lalloo, D G, Leslie, T, Magnussen, P, Mangham-Jefferies, L, Mårtensson, A, Mayan, I, Mbonye, A K, Msellem, M I, Onwujekwe, O E, Owusu-Agyei, S, Rowland, M W, Shakely, D, Staedke, S G, Vestergaard, L S, Webster, J, Whitty, C J M, Wiseman, V L, Yeung, S, Schellenberg, D & Hopkins, H 2017, ' The impact of introducing malaria rapid diagnostic tests on fever case management : A synthesis of ten studies from the ACT Consortium ', American Journal of Tropical Medicine and Hygiene, vol. 97, no. 4, pp. 1170-1179 . https://doi.org/10.4269/ajtmh.16-0955
The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Since 2010, the World Health Organization has been recommending that all suspected cases of malaria be confirmed with parasite-based diagnosis before treatment. These guidelines represent a paradigm shift away from presumptive antimalarial treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00427a0897eeae37a12519c602eeb19d
https://curis.ku.dk/portal/da/publications/the-impact-of-introducing-malaria-rapid-diagnostic-tests-on-fever-case-management(c594268a-b114-48b6-ae95-333b74fcaa3b).html
https://curis.ku.dk/portal/da/publications/the-impact-of-introducing-malaria-rapid-diagnostic-tests-on-fever-case-management(c594268a-b114-48b6-ae95-333b74fcaa3b).html
Autor:
Whitney E. Harrington, Stephen J. Rogerson, Ebbie Chaluluka, Linda Kalilani-Phiri, Morgan M. Goheen, Steven R. Meshnick, Mwayi Madanitsa, Antoinette Tshefu, Edward Kabyemela, Steve M. Taylor, Alejandro L. Antonia, Victor Mwapasa, Carole Khairallah, Feiko O. ter Kuile, Michal Fried, Patrick E. Duffy
Publikováno v:
Emerging infectious diseases, 20(7), 1140-1148. Centers for Disease Control and Prevention (CDC)
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 20, Iss 7, Pp 1140-1148 (2014)
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 20, Iss 7, Pp 1140-1148 (2014)
Parasites with increased resistance to sulfadoxine might undermine malaria control measures.
Sulfadoxine-resistant Plasmodium falciparum undermines malaria prevention with sulfadoxine/pyrimethamine. Parasites with a highly resistant mutant dihyd
Sulfadoxine-resistant Plasmodium falciparum undermines malaria prevention with sulfadoxine/pyrimethamine. Parasites with a highly resistant mutant dihyd